These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20930390)

  • 1. Comparative study of skin permeation profiles between brand and generic tulobuterol patches.
    Yoshihara S; Fukuda H; Abe T; Arisaka O
    Biol Pharm Bull; 2010; 33(10):1763-5. PubMed ID: 20930390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Model analysis of tulobuterol patch formulations to explain the influence of drug release rate and transdermal transfer rate on the plasma concentration profile].
    Watanabe T; Satoh H; Hori S; Miki A; Ohtani H; Sawada Y
    Yakugaku Zasshi; 2011; 131(10):1483-92. PubMed ID: 21963976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Questionnaire survey on the change of asthmatic response, adverse events and product usability due to drug switching between name-brand and generic tulobuterol tapes].
    Izumi T; Hori S; Satoh H; Miki A; Sawada Y
    Yakugaku Zasshi; 2012; 132(5):617-27. PubMed ID: 22687698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin permeability of tulobuterol in two transdermal formulations and their followability.
    Takizawa Y; Goto T; Sato S; Ohmori N; Mori K; Shimada Y; Chen K; Miyagi T; Fukai F
    Drug Discov Ther; 2017 Nov; 11(5):253-258. PubMed ID: 29021505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence of marketed transdermal delivery systems for tulobuterol.
    Tojo K; Hikima T
    Biol Pharm Bull; 2007 Aug; 30(8):1576-9. PubMed ID: 17666825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of monolithic matrix patch system containing tulobuterol.
    Rhee YS; Kwon SY; Park CW; Choi NY; Byun WJ; Chi SC; Park ES
    Arch Pharm Res; 2008 Aug; 31(8):1029-34. PubMed ID: 18787793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of patch formulation of tulobuterol, a long-acting beta2-adrenoreceptor agonist, in the treatment of severe pediatric asthma.
    Yoshihara S; Yamada Y; Abe T; Arisaka O
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):879-80. PubMed ID: 16802779
    [No Abstract]   [Full Text] [Related]  

  • 8. A 12-week, randomized, parallel-group, proof-of-concept study of tulobuterol patch and salmeterol inhaler as add-on therapy in adult-onset mild-to-moderate asthma.
    Inoue H; Niimi A; Matsumoto H; Ito I; Oguma T; Otsuka K; Takeda T; Nakaji H; Tajiri T; Iwata T; Nagasaki T; Mishima M
    Clin Exp Pharmacol Physiol; 2017 Jan; 44(1):21-29. PubMed ID: 27718262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal tulobuterol patch, a long-actingβ(2)-agonist.
    Tamura G; Ichinose M; Fukuchi Y; Miyamoto T
    Allergol Int; 2012 Jun; 61(2):219-29. PubMed ID: 22270072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of the beta 2-adrenoceptor agonist, tulobuterol, given transdermally and by inhalation.
    Uematsu T; Nakano M; Kosuge K; Kanamaru M; Nakashima M
    Eur J Clin Pharmacol; 1993; 44(4):361-4. PubMed ID: 8099880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of the β2-adrenoceptor agonist, tulobuterol, in Beagle dogs following transdermal and intravenous administration.
    Kim JH; Kim TH; Park HJ; Choi YJ; Kang JH; Song KH; Koo TS; Seo KW
    Vet J; 2016 Feb; 208():90-2. PubMed ID: 26639828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The efficacy and safety of tulobuterol tape in mild and moderate persistent asthma patients].
    Su N; Lin JT; Yang M; Chen X; He J; He QY; Cao ZL; Chen BY; Xiao Y; Yan XX
    Zhonghua Nei Ke Za Zhi; 2007 Jan; 46(1):39-42. PubMed ID: 17331388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive effects of transdermal tulobuterol to inhaled tiotropium in patients with COPD.
    Ichinose M; Seyama K; Nishimura M; Fukuchi Y; Nagai A; Mishima M; Kubo K;
    Respir Med; 2010 Feb; 104(2):267-74. PubMed ID: 19875277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of a tulobuterol patch with improved mechanical properties: effect of transdermal permeation enhancers on the release process of metal ligand-based acrylic pressure-sensitive adhesives.
    Nan L; Song H; Wang H; Mi R; Wang X; Fang L
    Drug Deliv Transl Res; 2024 Mar; 14(3):802-811. PubMed ID: 38082031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the predicted time-concentration profile of serum tulobuterol in human after transdermal application.
    Nakamura A; Mori D; Tojo K
    Chem Pharm Bull (Tokyo); 2012; 60(3):300-5. PubMed ID: 22382408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Drug-in-Adhesive Patch with a Honeycomb Film as a Backing Layer.
    Suzuki T; Sakisako Y; Kurihara Y; Aoki T; Kanematsu T; Todo H; Sugibayashi K
    Chem Pharm Bull (Tokyo); 2018; 66(9):851-858. PubMed ID: 30175741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of transdermal tulobuterol in pediatric asthma patients on long-term leukotriene receptor antagonist therapy: results of a randomized, open-label, multicenter clinical trial in Japanese children aged 4-12 years.
    Katsunuma T; Fujisawa T; Nagao M; Akasawa A; Nomura I; Yamaoka A; Kondo H; Masuda K; Yamaguchi K; Terada A; Ikeda M; Nishioka K; Adachi Y; Kurihara K
    Allergol Int; 2013 Mar; 62(1):37-43. PubMed ID: 23000726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler.
    Kobayashi Y; Yasuba H; Kudou M; Kita H
    J Asthma; 2007 Mar; 44(2):77-81. PubMed ID: 17454319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of tulobuterol patch and salmeterol in moderate to severe asthma.
    Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Kume H; Shimokata K
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1016-21. PubMed ID: 17042908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of a patch formulation of tulobuterol on cough scores and PEF in patients with cough variant asthma].
    Fujimori K; Suzuki E; Gejyo F
    Arerugi; 2000 Aug; 49(8):658-61. PubMed ID: 11021018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.